103 related articles for article (PubMed ID: 33336594)
1. Expression of NOTCH receptors and ligands and prognosis of hepatocellular carcinoma.
Zhao B; Hu S; Xiao Q; Fan S; Yu X; Li C; Dong P; Zheng J
Biomark Med; 2020 Dec; 14(17):1631-1639. PubMed ID: 33336594
[No Abstract] [Full Text] [Related]
2. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
[TBL] [Abstract][Full Text] [Related]
3. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
[TBL] [Abstract][Full Text] [Related]
4. Liver cancer: Different effects of the Notch receptors in liver cancer revealed.
Greenhill C
Nat Rev Gastroenterol Hepatol; 2014 Dec; 11(12):703. PubMed ID: 25348850
[No Abstract] [Full Text] [Related]
5. The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.
Gil-García B; Baladrón V
Biol Cell; 2016 Feb; 108(2):29-40. PubMed ID: 26621221
[TBL] [Abstract][Full Text] [Related]
6. A cell autonomous role for the Notch ligand Delta-like 3 in αβ T-cell development.
Hoyne GF; Chapman G; Sontani Y; Pursglove SE; Dunwoodie SL
Immunol Cell Biol; 2011 Aug; 89(6):696-705. PubMed ID: 21151194
[TBL] [Abstract][Full Text] [Related]
7. Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma.
Mizuno Y; Maemura K; Tanaka Y; Hirata A; Futaki S; Hamamoto H; Taniguchi K; Hayashi M; Uchiyama K; Shibata MA; Otsuki Y; Kondo Y
Oncol Rep; 2018 May; 39(5):2209-2216. PubMed ID: 29512761
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
9. The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice.
Deng SM; Yan XC; Liang L; Wang L; Liu Y; Duan JL; Yang ZY; Chang TF; Ruan B; Zheng QJ; Han H
Biochem Biophys Res Commun; 2017 Jan; 483(1):488-494. PubMed ID: 28007595
[TBL] [Abstract][Full Text] [Related]
10. Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.
Maimaiti A; Wang X; Hao Y; Jiang L; Shi X; Pei Y; Feng Z; Kasimu M
J Mol Neurosci; 2021 Aug; 71(8):1622-1635. PubMed ID: 33713320
[TBL] [Abstract][Full Text] [Related]
11. Effects of mRNA expression of five Notch ligands on prognosis of gastric carcinoma.
Li Y; Xie F; Zhang H; Wu X; Ji G; Li J; Hong L
Sci Rep; 2022 Sep; 12(1):15141. PubMed ID: 36071128
[TBL] [Abstract][Full Text] [Related]
12. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
13. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract][Full Text] [Related]
14. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
[TBL] [Abstract][Full Text] [Related]
15. Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.
Geffers I; Serth K; Chapman G; Jaekel R; Schuster-Gossler K; Cordes R; Sparrow DB; Kremmer E; Dunwoodie SL; Klein T; Gossler A
J Cell Biol; 2007 Jul; 178(3):465-76. PubMed ID: 17664336
[TBL] [Abstract][Full Text] [Related]
16. Dll3 is expressed in developing hair cells in the mammalian cochlea.
Hartman BH; Hayashi T; Nelson BR; Bermingham-McDonogh O; Reh TA
Dev Dyn; 2007 Oct; 236(10):2875-83. PubMed ID: 17823936
[TBL] [Abstract][Full Text] [Related]
17. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of Notch receptors in human hepatocellular carcinoma.
Gao J; Song Z; Chen Y; Xia L; Wang J; Fan R; Du R; Zhang F; Hong L; Song J; Zou X; Xu H; Zheng G; Liu J; Fan D
Dig Liver Dis; 2008 Feb; 40(2):114-21. PubMed ID: 17920003
[TBL] [Abstract][Full Text] [Related]
19. CFHR3 is a potential novel biomarker for hepatocellular carcinoma.
Liu J; Li W; Zhao H
J Cell Biochem; 2020 Apr; 121(4):2970-2980. PubMed ID: 31709629
[TBL] [Abstract][Full Text] [Related]
20. Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Zhang Y; Li D; Feng F; An L; Hui F; Dang D; Zhao Q
Sci Rep; 2017 Nov; 7(1):14809. PubMed ID: 29093570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
